FDA Inspection 1147009 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - July 12, 2021

FDA Inspection 1147009 for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company on July 12, 2021. Classification: Voluntary Action Indicated (VAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1147009 for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company on July 12, 2021. Classification: Voluntary Action Indicated (VAI).

Violation Codes

21 CFR 211.113(b)

21 CFR 211.160(b)

21 CFR 211.165(d)

21 CFR 211.22(d)

21 CFR 211.56(a)

21 CFR 211.68(b)

21 CFR 820.100(b)

21 CFR 820.30(f)

21 CFR 820.50

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

Inspection Date

July 12, 2021

Product Type

Devices

Office

Center for Devices and Radiological Health

ID: 13fb3933-f63f-4abe-99ce-c7f89d541a37

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox